OSCR

Development of an <i>in vivo</i>, screenable, split-luciferase based model of huntingtin multimerization.

Overview

Authors: Morgan G Thomas1, Simon A Levy2, Meredith H Jenkins1, Morgan Lambert1, Bess Frost1
  1. Center for Alzheimer’s Disease Research, Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, USA
  2. Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA
Journal: iScience, volume 29, issue 7, article 116660
Dates: received 1 October 2025; accepted 17 June 2026; published online 7 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.isci.2026.116660 · PMID 42436982 · PMCID PMC13355796 · OpenAlex W7167605648
Open access: gold, a free copy (OpenAlex)
Status: code on request
Categories: drosophila (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Huntington’s disease, huntingtin, polyglutamine, Drosophila, split-luciferase
Topic: Genetic Neurodegenerative Diseases (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Funding: National Institutes of Health (P40OD018537); NINDS NIH HHS (T32 NS082145); National Institute of Child Health and Human Development (IA 52242); NINDS (T32 NS082145); NIH HHS (P40 OD018537)
Citations: not cited yet (Europe PMC); 36 references in the paper
Research resources: Alexa Fluor 488 anti-rabbit RRID:AB_143165, Alexa Fluor 647 anti-mouse RRID:AB_2535804, Anti-mouse human ads-HRP RRID:AB_2619742, Huntingtin RRID:AB_2792860, Anti-rabbit human ads-HRP RRID:AB_2795919, Actin RRID:AB_528068, Lamin Dm0 RRID:AB_528338, pUA Plasmid RRID:Addgene_58372, W1118 RRID:BDSC_3605, Elav-Gal4 RRID:BDSC_458, GraphPad Prism RRID:SCR_002798

Abstract

Huntington’s disease is a neurodegenerative disorder caused by a polyglutamine (polyQ) expansion in exon one of the gene that encodes for the protein huntingtin (HTT). PolyQ expansion drives HTT aggregation into multimeric species that range from soluble oligomers to fibrillar, insoluble inclusion bodies. Cellular mechanisms facilitating HTT aggregation are incompletely understood, hindering efforts to develop strategies that prevent inclusion body formation or promote clearance of misfolded protein. To enable future unbiased in vivo screening approaches to identify genetic modifiers and pharmacological strategies to suppress HTT aggregation, we have developed HTTLUM, a split-luciferase-based detector of HTT-HTT interaction in adult Drosophila melanogaster neurons. This system permits real-time monitoring of HTT multimerization in living, active flies. The non-lethal nature of the HTTLUM system enables subsequent analysis of HTT aggregation, neurotoxicity, and other phenotypes in the same flies, thus serving as a platform for medium-throughput screening followed by mechanistic validation of potential modifier candidates.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Data and code availability

All raw and processed data generated in this paper are available from the lead contact upon request.

This study does not report original code.

Any additional information required to reanalyze the data reported in this study is available from the lead contact upon request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 keywords, 5 funders, 36 references, 11 RRIDs.

Cite

This paper

Thomas, M. G., Levy, S. A., Jenkins, M. H., Lambert, M., & Frost, B. (2026). Development of an <i>in vivo</i>, screenable, split-luciferase based model of huntingtin multimerization. iScience, 29(7), 116660. https://doi.org/10.1016/j.isci.2026.116660

BibTeX

@article{thomas2026development,
author = {Thomas, Morgan G and Levy, Simon A and Jenkins, Meredith H and Lambert, Morgan and Frost, Bess},
title = {{Development of an \<i\>in vivo\</i\>, screenable, split-luciferase based model of huntingtin multimerization}},
journal = {iScience},
year = {2026},
month = jul,
volume = {29},
number = {7},
pages = {116660},
publisher = {Elsevier},
issn = {2589-0042},
doi = {10.1016/j.isci.2026.116660},
url = {https://doi.org/10.1016/j.isci.2026.116660},
pmid = {42436982},
pmcid = {PMC13355796}
}

RIS

TY - JOUR
AU - Thomas, Morgan G
AU - Levy, Simon A
AU - Jenkins, Meredith H
AU - Lambert, Morgan
AU - Frost, Bess
TI - Development of an <i>in vivo</i>, screenable, split-luciferase based model of huntingtin multimerization
T2 - iScience
J2 - iScience
PY - 2026
DA - 2026/07/07
VL - 29
IS - 7
SP - 116660
SN - 2589-0042
PB - Elsevier
DO - 10.1016/j.isci.2026.116660
UR - https://doi.org/10.1016/j.isci.2026.116660
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.isci.2026.116660",
"type": "article-journal",
"title": "Development of an <i>in vivo</i>, screenable, split-luciferase based model of huntingtin multimerization",
"container-title": "iScience",
"author": [
{
"family": "Thomas",
"given": "Morgan G"
},
{
"family": "Levy",
"given": "Simon A"
},
{
"family": "Jenkins",
"given": "Meredith H"
},
{
"family": "Lambert",
"given": "Morgan"
},
{
"family": "Frost",
"given": "Bess"
}
],
"container-title-short": "iScience",
"volume": "29",
"issue": "7",
"page": "116660",
"DOI": "10.1016/j.isci.2026.116660",
"PMID": "42436982",
"PMCID": "PMC13355796",
"ISSN": "2589-0042",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.isci.2026.116660",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
7
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1080/19491034.2026.2697135
Elevation of the mechanically-sensitive e protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons.
Journal: Nucleus (Austin, Tex.)
In common: cellular / molecular, 2 authors
[2] doi:10.1038/s44321-026-00459-9
Anle138b ameliorates pathological phenotypes in mouse and cellular models of Huntington's disease.
Journal: EMBO molecular medicine
In common: other condition, cellular / molecular, 3 references
[3] doi:10.1186/s11658-026-00948-2 [code]
Phosphoproteomic profiling reveals post-translational dysregulation in Huntington's disease patient-derived neurons.
Journal: Cellular & molecular biology letters
In common: other condition, 2 references
[4] doi:10.1038/s41467-026-71351-w [code]
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.
Journal: Nature communications
In common: drosophila, other condition, cellular / molecular, 1 reference
[5] doi:10.1371/journal.pgen.1012260
Hippo signaling regulates cuticle pigmentation and dopamine metabolism in Drosophila.
Journal: PLoS genetics
In common: drosophila, cellular / molecular, 1 reference
[6] doi:10.3390/biomedicines14071484
HDDF2-A Novel Patient-Derived Fibroblast Line from Huntington's Disease with Prominent Cellular Senescence and polyQ Pathology.
Journal: Biomedicines
In common: other condition, 1 reference
[7] doi:10.1038/s41598-026-56101-8
Topological modeling of gene expression in the brain with Huntington's disease reveals selective disruption of co-expression network.
Journal: Scientific reports
In common: other condition, cellular / molecular, 1 reference
[8] doi:10.1242/dmm.052803
Molecular features of a Huntington's disease knock-in minipig.
Journal: Disease models & mechanisms
In common: other condition, cellular / molecular, 1 reference
[9] doi:10.1177/18796397261443137 [code]
Towards AI-driven prediction of <i>HTT</i> CAG size in super-expanded human spiny projection neurons from Huntington disease donors.
Journal: Journal of Huntington's disease
In common: other condition, cellular / molecular, 1 reference
[10] doi:10.1016/j.isci.2026.117125
Brain circadian clock neurons drive fitness advantages in <i>Drosophila</i>.
Journal: iScience
In common: drosophila, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.